The NanoMedicines Innovation Network (NMIN) is pleased to introduce the 2023-24 Executive Committee of its Highly Qualified Personnel (HQP) Network – the NMIN HQP Network (NHN). The NHN Executive Committee is comprised entirely of NMIN HQP, and plays a leadership role in the planning and realization of NMIN’s HQP programs,… Read More »Announcing the 2023-24 NHN Executive Committee
The NanoMedicines Innovation Network (NMIN) is pleased to announce the recipient of its 2021 NMIN Postdoctoral Fellowship in Gene Therapy: Dr. Miffy Hok Yan Cheng. The awardee was selected by the members of NMIN’s Research Management Committee, based on the applicant’s qualifications, as well as the quality of the proposed… Read More »2021 NMIN Postdoctoral Fellowship in Gene Therapy winner announced
The NanoMedicines Innovation Network (NMIN) is pleased to announce the recipient of its inaugural NMIN Postdoctoral Award in Diagnostics: Dr. Yih Yang (Ian) Chen. The awardee was selected by the members of NMIN’s Research Management Committee, based on the applicant’s qualifications, as well as the quality of the proposed research… Read More »Inaugural NMIN Postdoctoral Award in Diagnostics winner announced
The NanoMedicines Innovation Network (NMIN) is pleased to introduce the 2021-22 Executive Committee of its Highly Qualified Personnel (HQP) Network – the NMIN HQP Network (NHN). The NHN Executive Committee is comprised entirely of NMIN HQP, and plays a leadership role in the planning and realization of NMIN’s HQP programs,… Read More »Announcing the 2021-22 NMIN HQP Network Leadership Team
Top L to R: Brenna Rauw, Stephen Dibert, Inès Holzbaur, Wendy Lamson. Bottom L to R: Lihn Le, Helen Loughrey, Paul Santerre, Andrew Sinclair, Gary Skarja. The NanoMedicines Innovation Network (NMIN) is pleased to introduce the inaugural members of its Commercialization Advisory Board (CAB). The Commercialization Advisory Board (CAB) provides… Read More »Meet NMIN’s Commercialization Advisory Board (CAB)
The NanoMedicines Innovation Network (NMIN) is pleased to announce the third recipient of an NMIN-Mitacs Internship. In an internship of one year’s duration, Dr. Farahnaz Fathordoobady, NMIN HQP and Postdoctoral Fellow at the University of British Columbia (UBC), will collaborate with Ascension Sciences Inc. (ASI) to develop a novel oral… Read More »NMIN-Mitacs Intern developing novel cannabinoid delivery platforms
The NanoMedicines Innovation Network (NMIN) is pleased to announce the inaugural recipients of NMIN-Mitacs Internships: Drs. Kent Chen and Brian Hsu will both work with Cuprous Pharmaceuticals Inc. (CPI) on the development of novel nanomedicines to induce anticancer immunity, using CPI’s proprietary Metaplex technology. Dr. Kent Chen Dr. Brian Hsu… Read More »Inaugural NMIN-Mitacs Internships at Cuprous Pharmaceuticals Inc.
The NanoMedicines Innovation Network (NMIN) is pleased to introduce the inaugural members of its Highly Qualified Personnel (HQP) Program Advisory Committee (HPAC). The HQP Program Advisory Committee advises the Research Management Committee (RMC) of NMIN on training and programming opportunities that will increase the knowledge, skills and expertise of trainees… Read More »Meet NMIN’s HQP Program Advisory Committee (HPAC)
NMIN HQP Morgan Alford has been named a 2020 Vanier Canada Graduate Scholarship recipient. Morgan is a PhD candidate supervised by NMIN researcher Dr. Robert Hancock at the University of British Columbia, and is a member of the Executive Committee (Communications Director) of the NMIN HQP Network (NHN). Her research… Read More »NMIN trainee awarded Vanier Scholarship
The NanoMedicines Innovation Network (NMIN) is pleased to introduce the inaugural Executive Committee of its Highly Qualified Personnel (HQP) Network – the NMIN HQP Network (NHN). The NHN Executive Committee is comprised entirely of NMIN HQP, and plays a leadership role in the planning and realization of NMIN’s HQP programs,… Read More »Announcing the NMIN HQP Network Leadership Team